Elsa Marques

Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy

Heidi M. Haikala, Johanna M. Anttila, Elsa Marques et al. · Nature Communications · 2019 · 79 citations · Full text

Apoptosis, Immunology, Cell Death +19

Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion

Topi A. Tervonen, Denis Belitškin, Shishir M. Pant et al. · Oncogene · 2015 · 51 citations

Hgf/met Signalling, Signal Transduction, Signaling Pathway +11

Suppression of Early Hematogenous Dissemination of Human Breast Cancer Cells to Bone Marrow by Retinoic Acid–Induced 2

Stefan Werner, Benedikt Brors, Julia Eick et al. · Cancer Discovery · 2015 · 49 citations

Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers

Elsa Marques, Johanna I. Englund, Topi A. Tervonen et al. · Oncogene · 2015 · 27 citations · Full text

Myc requires RhoA/SRF to reprogram glutamine metabolism

Heidi M. Haikala, Elsa Marques, Mikko Turunen et al. · Small GTPases · 2016 · 21 citations · Full text

Cancer Research, Glutamine Metabolism, Oncogenic Myc +14